Docket Number:11A-980630
Inventor: Rita P.-Y. Chen, Steven Sheng-Shih Wang, Chaur-Jong Hu
IP Status:US9,074,238
Abstract:
Neprilysin (NEP) has been singled out as the most promising candidate for use in the degradation of A�� as a therapy for Alzheimer’s disease. In this study, a quenched fluorogenic peptide substrate containing the first seven residues of the A�� peptide plus a C-terminal Cys residue was synthesized to detect neprilysin activity. A fluorophore was attached to the C-terminal Cys and its fluorescence was quenched by a quencher linked to the N-terminus of the peptide. When this peptide substrate was degraded by an endopeptidase, fluorescence was produced and proved to be a sensitive detection system for endopeptidase activity. Our results showed that this assay system was extremely sensitive to NEP and insulin degrading enzyme, but insensitive, or much less sensitive, to other A��-degrading enzymes. Moreover, on the basis of our findings, a cell-based assay system was developed for the high-throughput screening of chemicals that are able to enhance NEP production in human SH-SY5Y cells.
Fields of Application:
- High sensitive detection of neprilysin
- High sensitive detection of insulin degrading enzyme
- This cell-based assay system can be used to high- throughput screen compounds which promote NEP production in cells.
- Therapeutics of Alzheimer’s disease
Advantages when compared to the existing technologies:
The synthesis of our peptide substrate is easy and with high yield. The emitted fluorescence can be fast detected in a 96-well microplate using spectrofluorometer. This substrate has enzyme selectivity. It is high sensitive to NEP and IDE, but inert to other A��-degrading enzymes. It can detect as low as 0.46 nM NEP. Although there is another patent (US Pat. 10512588 - Filed Apr 24, 2003) describing a methos to measure neprilysin activity and screen compounds which can enhance production or activity of neprilysin. However, this patent disclosed a method of visualizing the activity of neprilysin in nerve cells using a substrate glutaryl-alanyl-alanyl-phenylalanyl-4-methoxy-2-naphthylamide. When the substrate is degraded by neprilysin and aminopeptidase, the degraded product, 4-methoxy-2-naphthylamine, interacts with nitrosalicylaldehyde to form an insoluble yellow fluorescence substance. The neprilysin activity was quantified from the stained image by confocal laser scanning microscope. Their method is more complicate and slower. No enzyme selectivity has been mentioned. Our method is different. Because neprilysin is a membrane protein, we used a quenched fluorogenic peptide as a substrate for neprilysin on membrane. This peptide is soluble. This peptide has a fluorophore and a quencher attached at its two ends. The fluorescence is quenched due to the existence of the quencher. When it is cleaved by neprilysin, the fluorescence is no longer be quenched. The fluorescence increases. Compound for screening is added into medium containing human SH-SY5Y cells, then this quenched fluorogenic peptide is added. If the cells have more neprilysin production, the fluorescence in the medium is higher. The fluorescence is detected on a 96-well microplate. Only 200 �愮 culture medium is enough for detection. One milligram of the synthetic peptide substrate could be used to screen more than six thousand compounds. It is ideal for high throughput screening compounds which can enhance neprilysin production of cell.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
